ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentEpalingesNovigenix AI SA
Novigenix AI SA Logo
Verified· 3 sourcesTrust Score
Summary

About the company

Novigenix AI SA develops liquid biopsy and multi-omics solutions based on the LITOSeek™ platform for immuno-transcriptomics analysis. The company uses AI and RNA data to discover biomarkers, predict therapy response, and support the development of cancer treatments.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentMedical Laboratories
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.8/5

Novigenix AI SA

Medical Technology Industry
✓ Offered2
Liquid Biopsy Analytics Platform (LITOSeek)
Liquid biopsy analytics platform for RNA and multi-omics analysis, biomarker-based modelling, quality control and visualization of immuno-transcriptomic data from blood and tumour samples.
Translational Medicine for Precision Oncology
Translational medicine solutions for precision oncology, including ImmunoPD response markers, predictive biomarkers of response and resistance, safety biomarkers, and digital cytometry and cellular deconvolution.
Trust & reputation

ranQ Trust Score of Novigenix AI SA: 3.8 out of 5.0

Trust Score3.8/ 5.0

High

x

Data basis 58% · As of October 2026

Novigenix AI SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Novigenix AI SA scores 53.4 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.25.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Novigenix AI SA scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Novigenix AI SA scores 52.4 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.71.44%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.33.34%
Qualifications+0.00

Novigenix AI SA reaches a ranQ Trust Score of 3.8 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

April 21, 2026Media
Three Swiss biotechs secure regulatory and clinical milestones
startupticker.ch
October 3, 2024Media
EU funds AI-driven medical projects powered by Swiss startups
startupticker.ch

Knowledge

No knowledge articles yet

Once Novigenix AI SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Novigenix AI SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Novigenix AI SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Novigenix AI SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Route de la Corniche 3
1066 Epalinges

At a glance

Legal form
Corporation
UID
CHE-301.015.916
Founded
2025 · 1 year
Last commercial register change
July 16, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AT
    ADC Therapeutics SA
    Epalinges
    TB
    TwinEdge Bioscience SA
    Epalinges
    OB
    Opna Bio Switzerland Sàrl
    Epalinges
    NS
    NewBiologix SA
    Epalinges
    MS
    MoleSense Sàrl
    Epalinges
    SS
    Sylex SA
    Epalinges
    AI
    AC Immune SA
    Lausanne
    FA
    Fondation Alamaya : neuroscience et psychiatrie
    La Tour-De-Peilz